{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:08:12Z","timestamp":1782601692889,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Antiphospholipid antibody syndrome (APS) is an autoantibody-mediated thrombophilic disorder that causes a hypercoagulable state and can lead to venous thromboembolism, stroke, multiple miscarriages, and other pregnancy complications with the presence of antiphospholipid antibodies. This article reviews screening, diagnosis, and management of APS with a focus on the prevention of long-term complications.<\/jats:p>","DOI":"10.1097\/01.jaa.0000526771.67820.59","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T19:40:24Z","timestamp":1510170024000},"page":"10-14","source":"Crossref","is-referenced-by-count":14,"title":["Antiphospholipid antibody syndrome"],"prefix":"10.1097","volume":"30","author":[{"given":"Kerry L.","family":"Whitaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"9","key":"R1-20230829","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/asheducation-2007.1.136","article-title":"The antiphospholipid syndrome","author":"Rand","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"704395","DOI":"10.1155\/2014\/704395","article-title":"Isolated IgA anti-b2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome","volume":"2014","author":"Ruiz-Garc\u00eda","year":"2014","journal-title":"J Immunol Res"},{"issue":"2","key":"R4-20230829","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/S0482-50042013000200005","article-title":"Guidelines for the treatment of antiphospholipid syndrome","volume":"53","author":"Danowski","year":"2013","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"R5-20230829","first-page":"CD004734","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"R7-20230829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"R8-20230829","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"13","author":"Bertolaccini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48-49","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"J Autoimmun"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R11-20230829","article-title":"Antiphospholipid syndrome and pregnancy","author":"Berg"},{"key":"R12-20230829","article-title":"Antiphospholipid syndrome","author":"Movva"},{"issue":"17","key":"R13-20230829","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"issue":"1","key":"R14-20230829","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2011.153817","article-title":"Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study","volume":"71","author":"Martinez-Zamora","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-016-0043-2","article-title":"Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay","volume":"14","author":"Sciascia","year":"2016","journal-title":"Clin Mol Allergy"},{"issue":"2","key":"R16-20230829","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"R17-20230829","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmunity Reviews"},{"issue":"9","key":"R18-20230829","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.autrev.2014.05.004","article-title":"Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder","volume":"13","author":"D'Ippolito","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01720610-201712000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T02:16:58Z","timestamp":1693275418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201712000-00002"}},"subtitle":["The difficulties of diagnosis"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000526771.67820.59","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}